Prostate cancer incidence and mortality rates vary worldwide. In the United States, prostate
cancer is the most common malignancy affecting men and is the second-leading cause of …

[Frontiers in Bioscience 11, 1388-1413, May 1, 2006] 1388 Prostate cancer epidemiology Ann
W. Hsing 1 and Anand P. Chokkalingam Page 1 [Frontiers in Bioscience 11, 1388-1413, May 1 …

BACKGROUND Although narrative reviews have concluded that there is strong support for
familial clustering of prostate carcinoma, the association has never systematically been …

It is difficult to identify genes that predispose to prostate cancer due to late age at diagnosis,
presence of phenocopies within high-risk pedigrees and genetic complexity. A genome …

BACKGROUND The widespread use of prostate‐specific antigen (PSA) screening has had
a tremendous impact on all aspects of the management of prostate carcinoma. Although …

Although prostate cancer is the most common malignancy to affect men in the Western
world, the molecular mechanisms underlying its development and progression remain …

The incidence of prostate cancer continues to increase in the US. Compared with other
common cancers such as those of the breast and lung, the causes of prostate cancer remain …

Prostate cancer is the most commonly diagnosed non-skin cancer in most western countries
(1). In the United States, it is the second leading cause of cancer death following only lung …

Carcinoma of the prostate is the most frequently diagnosed malignancy and the second
leading cause of death as a result of cancer in men in the United States and in many other …

Quantitative and structural genetic alterations cause the development and progression of
prostate cancer. A number of genes have been implicated in prostate cancer by genetic …